From: Physician preferences for non-metastatic castration-resistant prostate cancer treatment
Attributes | Attribute Labels | Levels |
---|---|---|
Overall Survival | Prolonging life | • 4 years and an additional 12 months |
• 4 years and an additional 6 months | ||
• 4 years and an additional 3 months | ||
Time to Pain Progression | Delay in time until pain progresses (develops or worsens) | • 3 years and an additional 12 months |
• 3 years and an additional 6 months | ||
• 3 years and an additional 3 months | ||
Fatigue | Fatigue (lack of energy) | • None |
• Mild-to-moderate (may affect daily activities) | ||
• Severe (affects self-care) | ||
Skin Rash | Skin rash | • None |
• Mild-to-moderate (30% of the body or less, may affect daily activities) | ||
• Severe (more than 30% of the body, requires treatment and affects self-care) | ||
Cognitive Problems | Cognitive problems | • None |
• Mild-to-moderate (may affect daily activities) | ||
• Severe (affects self-care) | ||
Serious Fall | Risk of a serious fall | • None |
• 5% (5 out of 100 people) | ||
• 8% (8 out of 100 people) | ||
Serious Fracture | Risk of a serious fracture | • None |
• 5% (5 out of 100 people) | ||
• 8% (8 out of 100 people) |